Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

GenGraph: a python module for the simple generation and manipulation of genome graphs.

Ambler JM, Mulaudzi S, Mulder N.

BMC Bioinformatics. 2019 Oct 25;20(1):519. doi: 10.1186/s12859-019-3115-8.

2.

Qualitative situational analysis of palliative care for adolescents with cancer and HIV in South Africa: healthcare worker perceptions.

Ngwenya N, Ambler J, Archary M.

BMJ Open. 2019 Jan 25;9(1):e023225. doi: 10.1136/bmjopen-2018-023225.

3.

Inspiration, innovation and integration: highlights from the third ICPCN conference on children's palliative care, 30 May to 2 June 2018, Durban, South Africa.

Downing J, Boucher S, Ambler J, Brand T, Sithole Z, Nkosi B, Meiring M, Gwyther E, Sithole L, Steel B, Daniels A.

Ecancermedicalscience. 2018 Sep 11;12:870. doi: 10.3332/ecancer.2018.870. eCollection 2018.

4.

EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.

Blumenthal MJ, Schutz C, Meintjes G, Mohamed Z, Mendelson M, Ambler JM, Whitby D, Mackelprang RD, Carse S, Katz AA, Schäfer G.

Cancer Epidemiol. 2018 Oct;56:133-139. doi: 10.1016/j.canep.2018.08.005. Epub 2018 Aug 31.

5.

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.

Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, Koeth L, Sei K; CLSI Methods Development and Standardization Working Group of the Subcommittee on Antimicrobial Susceptibility Testing.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01934-17. doi: 10.1128/JCM.01934-17. Print 2018 Apr. Review.

6.

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

Singh R, Almutairi M, Alm RA, Lahiri SD, San Martin M, Chen A, Ambler JE.

J Antimicrob Chemother. 2017 Oct 1;72(10):2796-2803. doi: 10.1093/jac/dkx214.

PMID:
29091195
7.

Extreme rituals in a BDSM context: the physiological and psychological effects of the 'Dance of Souls'.

Klement KR, Lee EM, Ambler JK, Hanson SA, Comber E, Wietting D, Wagner MF, Burns VR, Cutler B, Cutler N, Reid E, Sagarin BJ.

Cult Health Sex. 2017 Apr;19(4):453-469. doi: 10.1080/13691058.2016.1234648. Epub 2016 Oct 14. Erratum in: Cult Health Sex. 2017 Apr;19(4):i.

PMID:
27737624
8.

New Antimicrobial Agents  …  but No Susceptibility Tests!

Ambler JE, Krause KM, Steenbergen JN, Scangarella-Oman NE, Miller LA, Bhagwat SS, Serio AW, Chesnel L, Mahoney NM, Motyl MR, Critchley IA, Iaconis JP, Stone GG, Alder J, Xerri L, McCurdy SP, van Veenhuyzen DF, Grossman T, Echols RM, Williams G, Bradford PA.

Clin Infect Dis. 2016 Dec 1;63(11):1530-1531. Epub 2016 Aug 31. No abstract available.

PMID:
27581762
9.

IMA Genome-F 6: Draft genome sequences of Armillaria fuscipes, Ceratocystiopsis minuta, Ceratocystis adiposa, Endoconidiophora laricicola, E. polonica and Penicillium freii DAOMC 242723.

Wingfield BD, Ambler JM, Coetzee MP, de Beer ZW, Duong TA, Joubert F, Hammerbacher A, McTaggart AR, Naidoo K, Nguyen HD, Ponomareva E, Santana QS, Seifert KA, Steenkamp ET, Trollip C, van der Nest MA, Visagie CM, Wilken PM, Wingfield MJ, Yilmaz N.

IMA Fungus. 2016 Jun;7(1):217-27. doi: 10.5598/imafungus.2016.07.01.11. Epub 2016 Jun 21.

10.

Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.

Koeth LM, Apfalter P, Becker K, Gesu G, Martínez-Martínez L, Lahiri SD, Alm RA, Ambler J, Iaconis J.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):452-8. doi: 10.1016/j.diagmicrobio.2016.05.003. Epub 2016 May 8.

PMID:
27233426
11.

Spontaneous trait inference and spontaneous trait transference are both unaffected by prior evaluations of informants.

Zengel B, Ambler JK, McCarthy RJ, Skowronski JJ.

J Soc Psychol. 2017;157(3):382-387. doi: 10.1080/00224545.2016.1192099. Epub 2016 May 24.

PMID:
27220061
12.

Altered States of Consciousness during an Extreme Ritual.

Lee EM, Klement KR, Ambler JK, Loewald T, Comber EM, Hanson SA, Pruitt B, Sagarin BJ.

PLoS One. 2016 May 13;11(5):e0153126. doi: 10.1371/journal.pone.0153126. eCollection 2016.

13.

Proteogenomic Analysis of Mycobacterium smegmatis Using High Resolution Mass Spectrometry.

Potgieter MG, Nakedi KC, Ambler JM, Nel AJ, Garnett S, Soares NC, Mulder N, Blackburn JM.

Front Microbiol. 2016 Apr 5;7:427. doi: 10.3389/fmicb.2016.00427. eCollection 2016.

14.

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.

Biedenbach DJ, Alm RA, Lahiri SD, Reiszner E, Hoban DJ, Sahm DF, Bouchillon SK, Ambler JE.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):343-7. doi: 10.1128/AAC.01867-15. Print 2016 Jan.

15.

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.

Biedenbach DJ, Hoban DJ, Reiszner E, Lahiri SD, Alm RA, Sahm DF, Bouchillon SK, Ambler JE.

Antimicrob Agents Chemother. 2015 Dec;59(12):7873-7. doi: 10.1128/AAC.01833-15. Epub 2015 Sep 28.

16.

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.

Lahiri SD, McLaughlin RE, Whiteaker JD, Ambler JE, Alm RA.

J Antimicrob Chemother. 2015 Sep;70(9):2488-98. doi: 10.1093/jac/dkv131. Epub 2015 Jun 4.

PMID:
26045529
17.

Characterization of synapses in the rat subnucleus centralis of the nucleus tractus solitarius.

Babic T, Ambler J, Browning KN, Travagli RA.

J Neurophysiol. 2015 Jan 15;113(2):466-74. doi: 10.1152/jn.00598.2014. Epub 2014 Oct 29.

18.
19.

An Ethical Approach to Peeking at Data.

Sagarin BJ, Ambler JK, Lee EM.

Perspect Psychol Sci. 2014 May;9(3):293-304. doi: 10.1177/1745691614528214.

PMID:
26173265
20.

Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.

Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1511-7. doi: 10.1007/s10096-014-2089-8. Epub 2014 Apr 18.

PMID:
24744220
21.

Effects of subjective sexual arousal on sexual, pathogen, and moral disgust sensitivity in women and men.

Lee EM, Ambler JK, Sagarin BJ.

Arch Sex Behav. 2014 Aug;43(6):1115-21. doi: 10.1007/s10508-014-0271-9. Epub 2014 Mar 5.

PMID:
24595916
22.

Changes in transthoracic impedance during sequential biphasic defibrillation.

Deakin CD, Ambler JJ, Shaw S.

Resuscitation. 2008 Aug;78(2):141-5. doi: 10.1016/j.resuscitation.2008.02.024. Epub 2008 May 16.

PMID:
18486297
23.

Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.

Ambler J, Rennie R, Poupard J, Koeth L, Stass H, Endermann R, Choudhri S.

Diagn Microbiol Infect Dis. 2008 May;61(1):49-57. doi: 10.1016/j.diagmicrobio.2008.01.013. Epub 2008 Mar 14.

PMID:
18342475
25.

A survey of tracheostomy practice in a cardiothoracic intensive care unit.

Briggs S, Ambler J, Smith D.

J Cardiothorac Vasc Anesth. 2007 Feb;21(1):76-80. Epub 2006 May 18.

PMID:
17289484
28.

Post-shock myocardial stunning: a prospective randomised double-blind comparison of monophasic and biphasic waveforms.

Deakin CD, Ambler JJ.

Resuscitation. 2006 Mar;68(3):329-33. Epub 2005 Dec 27.

PMID:
16378672
29.

Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.

Fogarty C, Torres A, Choudhri S, Haverstock D, Herrington J, Ambler J.

Int J Clin Pract. 2005 Nov;59(11):1253-9.

PMID:
16236076
30.

The effect of prophylactic topical steroid cream on the incidence and severity of cutaneous burns following external DC cardioversion.

Ambler JJ, Zideman DA, Deakin CD.

Resuscitation. 2005 May;65(2):179-84. Epub 2005 Jan 15.

PMID:
15866398
31.
32.

The incidence and severity of cutaneous burns following external DC cardioversion.

Ambler JJ, Sado DM, Zideman DA, Deakin CD.

Resuscitation. 2004 Jun;61(3):281-8.

PMID:
15172706
33.
34.

Remifentanil for phaeochromocytoma resection.

Gande AR, Ambler JJ, Haw MP, Gill RS.

Anaesthesia. 2003 Feb;58(2):196-7. No abstract available.

36.

Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.

Lopez H, Vilches V, Scarano S, Stepanik D, Smayevsky J, Lemme L, Cardeñosa O, Ambler J, Sucari A.

Int J Antimicrob Agents. 2001 Oct;18(4):379-82.

PMID:
11691572
37.
38.
40.

The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors.

Hayler J, Kane PD, LeGrand D, Lugrin F, Menear K, Price R, Allen M, Cockcroft X, Ambler J, Butler K, Dunnet K, Mitchelson A, Talbot M, Tweed M, Wills N.

Bioorg Med Chem Lett. 2000 Jul 17;10(14):1567-70.

PMID:
10915052
41.

The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.

Baettig U, Brown L, Brundish D, Dell C, Furzer A, Garman S, Janus D, Kane PD, Smith G, Walker CV, Cockcroft X, Ambler J, Mitchelson A, Talbot MD, Tweed M, Wills N.

Bioorg Med Chem Lett. 2000 Jul 17;10(14):1563-6.

PMID:
10915051
42.
43.

Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potency.

Brundish D, Bull A, Donovan V, Fullerton JD, Garman SM, Hayler JF, Janus D, Kane PD, McDonnell M, Smith GP, Wakeford R, Walker CV, Howarth G, Hoyle W, Allen MC, Ambler J, Butler K, Talbot MD.

J Med Chem. 1999 Nov 4;42(22):4584-603.

PMID:
10579821
44.

Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60G.

Ambler J, Brown L, Cockcroft XL, Grütter M, Hayler J, Janus D, Jones D, Kane P, Menear K, Priestle J, Smith G, Talbot M, Walker CV, Wathey B.

Bioorg Med Chem Lett. 1999 May 3;9(9):1317-22.

PMID:
10340621
45.

The discovery of orally available thrombin inhibitors: optimisation of the P1 pharmacophore.

Ambler J, Bentley D, Brown L, Dunnet K, Farr D, Janus D, Le Grand D, Menear K, Mercer M, Talbot M, Tweed M, Wathey B.

Bioorg Med Chem Lett. 1999 Apr 19;9(8):1103-8.

PMID:
10328293
46.

Studies towards the identification of potent, selective and bioavailable thrombin inhibitors.

Ambler J, Baker E, Bentley D, Brown L, Butler K, Butler P, Farr D, Dunnet K, Le Grand D, Hayler J, Janus D, Jones D, Menear K, Mercer M, Smith G, Talbot M, Tweed M.

Bioorg Med Chem Lett. 1999 Mar 8;9(5):737-42.

PMID:
10201839
47.

The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668.

Ambler J, Baker E, Brown L, Butler P, Farr D, Dunnet K, Le Grand D, Janus D, Jones D, Menear K, Mercer M, Smith G, Talbot M, Tweed M.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3583-8.

PMID:
9934475
48.

Production of transgenic rice (Oryza sativa subspecies japonica cv. Taipei 309).

Buchholz WG, Teng W, Wallace D, Ambler JR, Hall TC.

Methods Mol Biol. 1998;81:383-96. No abstract available.

PMID:
9760528
49.

Pirfenidone reduces fibronectin synthesis by cultured human retinal pigment epithelial cells.

Zhang S, Shiels IA, Ambler JS, Taylor SM.

Aust N Z J Ophthalmol. 1998 May;26 Suppl 1:S74-6.

PMID:
9685030
50.

Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.

Goldsmith CE, Moore JE, Murphy PG, Ambler JE.

J Antimicrob Chemother. 1998 Mar;41(3):420-1. No abstract available.

PMID:
9578174

Supplemental Content

Loading ...
Support Center